The Lynx Group
2020 Eddie Ozzie Award Winner
Winner of Folio's 2020
Eddie & Ozzie Awards

2022 AVBCC Summit

October 19-21, 2022

New York Athletic Club, New York, NY

  • The Association for Value-Based Cancer Care (AVBCC) will once again be meeting in person at the New York Athletic Club. The live event will be invitation-only, limiting the number of guests to follow safety guidelines. There will be a virtual simulcast of the entire Summit for those who cannot join us in New York.

    The One Conference That Covers It All

    Join us for this exclusive invitational forum that provides invaluable time with more than 200 diverse experts representing every stakeholder of the cancer care ecosystem. Nearly 100% of attendees agreed the content, topics, sessions, and information were relevant and up-to-date.

    Top Reasons to Participate in the 2022 Summit

    • LEARN to stay competitive in the ever-changing field of oncology.
    • EXPLORE cutting-edge methodologies you can implement in your company or institution immediately.
    • ACCESS timely and accurate information from sources you can rely on.
    • GAIN insights from a diverse range of practitioners, pharmacists, payers, policymakers, and other key stakeholders.
    • NETWORK with nationally recognized thought leaders.

    Registration

    Please Note:
    The live event is available on a first come, first served basis due to limited capacity. Sponsors will be guaranteed the opportunity to attend live. The general public is encouraged to request an invite to join and will be notified when accepted.

    The AVBCC Summit continues to empower all oncology care professionals to maximize value in cancer care by focusing on clinical, cost, and access issues. Secure your seat at the table today!

  • Take a look at the exciting lineup for the 2022 Summit! Sessions feature experts and respected faculty from across the field. This is a must-attend event for all stakeholders in the cancer-care value equation. Secure your spot today!

    • Wednesday, October 19

      7:45am - 8:00am

      Orchestrating Optimal Change Through Value-Based Agreements - Welcome

      Workshop Chairs:

      Burt Zweigenhaft, PhD, DLitt
      Executive Director & Co-Founder, AVBCC
      Linde Finsrud Wilson, MBA
      Executive Director & Co-Founder, AIIH
      8:00am - 8:30am

      Value-Based Agreements: State of the Market Report

      Moderator:

      Burt Zweigenhaft, PhD, DLitt
      Executive Director & Co-Founder, AVBCC

      Faculty:

      Linde Finsrud Wilson, MBA
      Executive Director & Co-Founder, AIIH
      Michael Muldoon
      Senior Director, Upstream Partners
      Christopher Warren, MS
      Senior Associate, Upstream Partners
      8:30am - 9:30am

      Headwinds and Tailwinds Ahead for Value-Based Agreements

      Moderator:

      Lalan Wilfong, MD
      VP, Payer Relations and Practice Transformation, McKesson

      Faculty:

      Jeffrey Scott, MD
      President & Chief Medical Officer
      Integra Connect
      Beth Hamilton, MBA
      VP, Global Oncology Market Access and Pricing
      AstraZeneca
      John Fox, MD
      Senior Medical Director for the Americas
      Illumina
      Rani Khetarpal, MBA
      Head of Value Based Care Partnerships
      CVS Health

      Transitioning from Volume-Based Discounts to Value-Based Agreements

      Moderator:

      Michael Kolodziej, MD
      Senior Advisor, ADVI Health

      Faculty:

      Francois de Brantes, MBA
      SVP, Signify Health
      Alice Gosfield, JD
      Principal, Alice G Gosfield and Associates, PC
      Barry Fortner, PhD
      VP, Medical Affairs, US Oncology Business Unit
      Daiichi SankyoDaiichi Sankyo
      Joe Stevens, MBA
      Principal, ZS Associates
      Bryan Loy, MD
      Physician Lead, Oncology Laboratory and
      Personalized Medicine, Humana
      9:30am - 10:30am

      Defining the Value-Based Agreement Models Involving Pharma

      Moderator:

      Michael Kolodziej, MD
      Senior Advisor, ADVI Health

      Faculty:

      Francois de Brantes, MBA
      SVP, Signify Health
      Alice Gosfield, JD
      Principal, Alice G Gosfield and Associates, PC
      Barry Fortner, PhD
      VP, Medical Affairs, US Oncology Business Unit
      Daiichi SankyoDaiichi Sankyo
      Joe Stevens, MBA
      Principal, ZS Associates
      Bryan Loy, MD
      Physician Lead, Oncology Laboratory and
      Personalized Medicine, Humana

      The Simple Explanation on the Inflation Reduction Act and Impact on Healthcare Markets

      Moderator:

      Lindsay Bealor Greenleaf, JD, MBA
      VP, Policy, ADVI Health

      Faculty:

      John McManus
      Owner, The McManus Group
      10:30am - 11:30am

      The Practical Framework for Value-Based Agreements

      Moderator:

      William McGivney, PhD
      Managing Partner
      McGivney Global Advisors

      Faculty:

      Paul Jeffrey, PharmD
      Principal, Jeff℞ey Consulting
      Retired, Sr. Director of Pharmacy, MassHealth
      Neha Kashalikar, PharmD
      Clinical Consultant Pharmacist
      MassHealth Office of Clinical Affairs Commonwealth Medicine
      University of Massachusetts Chan Medical School
      Mahsa Salsabili, PharmD, PhD
      Pharmacoeconomics Specialist
      Clinical Pharmacy Services
      Commonwealth Medicine
      University of Massachusetts Chan Medical School
      10:30am - 11:30am

      Succeeding in Value-Based Payment Arrangements: ASCO’s Patient Centered Cancer Care Certification Pilot

      Moderator:

      Stephen Grubbs, MD, FASCO
      VP, Care Delivery
      American Society of Clinical Oncology

      Faculty:

      Andrew Chapman, DO, FACP
      Director Sidney Kimmel Cancer Center
      EVP Oncology Services Jefferson Health
      David Debono, MD
      Oncology Medical Director
      Elevance Health
      Larry Bilbrey
      Program Director
      Data & Analytics
      Tennessee Oncology
      Bo Gamble
      Director of Quality and Value
      Community Oncology Alliance
      Matthew Skelton, MD
      Medical Oncology/Hematology
      Blue Ridge Cancer Center
      11:30am - 12:15pm

      Defining the Value-Based Agreement Models Involving Pharma

      Moderator:

      Basit Chaudhry, MD, PhD
      Founder, Tuple Health

      Faculty:

      Lucas de Breed, MBA, PhD
      Founder, August Care
      Francois de Brantes, MBA
      SVP, Signify Health
      Roger Longman, MA
      Founder & Chairman, Real Endpoints
      Joe Stevens, MBA
      Principal, ZS Associates

      The Return of the Cancer Moonshot

      Moderator:

      Greg Simon
      Co-Founder, IMX Health Exchange
      CEO & CFO, Intelligent Medicine
      Acquisition Corp (IQMD)
      12:15pm - 1:15pm

      A Simple Explanation of BBBA / IRA and Impact on Healthcare Markets

      Faculty:

      Joe Grogan, JD
      Former Assistant to the President
      Director of the Domestic Policy Council
      1:15pm - 2:15pm

      Pharma Value-Based Programs: What Worked, Failed and Is the Future

      Moderator:

      John Fox, MD
      Senior Medical Director for the Americas
      Illumina

      Faculty:

      Michael Lynch, CPA, MBA
      Executive Director, Market Access
      Bayer
      Gergana Zlateva, MPA, PhD
      VP & Business Unit Lead, Oncology
      Patient & Health Impact
      Pfizer
      Nancy Bell
      Takeda Oncology

      Health Equity Integration in Value-Based Care, an Upstream Partnership

      Moderator:

      Michael Kolodziej, MD
      Senior Advisor
      ADVI Health

      Faculty:

      Barbara McAneny, MD
      Past President, American Medical Association
      Chair, National Cancer Care Alliance
      CEO, New Mexico Cancer Center
      Susan Sabo Wagner, MSN, RN, OCN
      Executive Director
      Clinical Strategy
      Oncology Consultants
      Alti Rahman, MHA, MBA, CSSBB
      Chair of Health Equity Committee
      Community Oncology Alliance
      Practice Administrator
      Oncology Consultants

      If It Works for Corn, it will Work for Cancer: Why Healthcare Needs a Futures Market -- and One is Coming

      Moderator:

      Jonathan Fassberg
      Vice Chairman
      Healthcare Investment Banking
      Oppenheimer

      Faculty:

      Greg Simon
      Co-Founder, IMX Health Exchange
      CEO & CFO, Intelligent Medicine
      Acquisition Corp (IQMD)
      2:15pm - 3:15pm

      Future Data Exchange Requirements to Support Value-Based Agreements

      Moderator:

      David Johnson, MD, MPH
      Clinical Operating Officer
      Rubicon Founders

      Faculty:

      Cory Wiegert
      COO, Integra Connect
      Tim Suther
      Senior VP
      Data Solutions
      Change Healthcare
      Shawn Huda
      Director of Project Management
      Flatiron Health
      Amy Valley, PharmD
      VP, Clinical Strategy and
      Technology Solutions
      Cardinal Health
      Specialty Solutions

      Legal and Regulatory Issues Surrounding Value-Based Agreements

      Moderator:

      Julie Ritchier Wagner, JD
      Head of Global Ethics
      Compliance and Enforcement Legal Policy
      Senior Assistant General Counsel
      PhRMA

      Faculty:

      Kristin Viswanathan Wolff, MPH
      VP, Market Access
      bluebird bio
      Jesse Dresser, Esq.
      Partner, Frier Levitt
      Joel Kurzman, MA
      Manager
      State Government Affairs
      AmerisourceBergen
      Ben Jones
      VP, Government Relations &
      Public Policy
      Andres Rodriguez, MS, MPH
      Director, Oncology Policy, GSK

      Wall Street and Capital Markets and the Impact on Cancer Care

      Moderator:

      Ipsita Smolinski, MBA, MPH
      Founder & Managing Partner
      Capitol Street

      Faculty:

      Umer Raffat
      Senior Managing Director
      Evercore ISI
      Lisa Gill
      Managing Director
      JP Morgan
      Brad Hively, MBA
      CEO, The Oncology Institute of
      Hope and Innovation
      Justin Sunshine, MBA
      Managing Director
      General Atlantic
      3:15pm - 4:15pm

      CMS: The Regulator Point of View

      Moderator:

      Michael Kolodziej, MD
      Senior Advisor, ADVI Health

      Faculty:

      Ellen Lukens, MPH
      Deputy Director
      Center for Medicare & Medicaid Innovation
      Centers for Medicare & Medicaid Services
      Hillary Cavanagh
      Deputy Director
      Division of Ambulatory Payment Models
      The Center for Medicare &
      Medicaid Innovation

      Creating Collaborative Partnerships: Stakeholder Perspectives

      Moderator:

      Susan Page, RN, BSN, MBA, MBB, MCA
      Chief Clinical Officer
      Patient Engagement Advisors

      Faculty:

      Aaron Lyss
      Senior Director
      Strategic Payer Relations
      OneOncology
      Kristin Viswanathan Wolff, MPH
      VP, Market Access
      bluebird bio
      Rani Khetarpal, MBA
      Head of Value Based Care Partnerships
      CVS Health
      Ranjani Durham
      Executive Director
      Value Strategy
      AstraZeneca

      Alignment of Patient Support Services to Enable Value-Based Contracting

      Moderator:

      Jeffrey Berkowitz, JD
      CEO, Real Endpoints
      4:15pm - 5:15pm

      Value-Based Agreement Roadmap from Strategy to Design Through Implementation

      Moderator:

      Lili Brillstein, MPH
      CEO, BCollaborative

      Faculty:

      Scott Kornhauser
      CEO, KlearTrust
      John Doyle, DrPH
      Group VP, Exponent
      Greg Gregory, PhD
      SVP, PRECISIONadvisors
      Tesh Khullar
      CEO & Co-Founder, House Rx
      Robert O'Brien
      VP, Specialty, Real Endpoints

      Understanding the Economics of the Oncology Drug Pricing Ecosystem

      Faculty:

      Jayson Slotnik, JD, MPH
      Partner, Health Policy Strategies

      Faculty:

      Antonio Ciaccia
      CEO, 46brooklyn Research & Axis Advisors
      Robert Popovian, PharmD, MS
      Founder, Conquest Advisors
      Eric Percher
      Senior Analyst
      Pharma Supply Chain & HCIT
      Nephron Research LLC
      5:15pm - 6:00pm

      Summarizing Business Case for Pharma Participation in Triangulated Value-Based Agreements

      Moderator:

      Jill DeSimone
      Former President, US Oncology, Merck

      Faculty:

      Daniel Switzer
      Head of US Oncology Business Division &
      Board of Director Member
      Daiichi Sankyo
      Diego Sacristan
      Regional President North America
      Oncology Pfizer
      Annette Powers, PharmD, MBA
      VP, Bristol Myers Squibb
      Beth Hamilton, MBA
      VP, Global Oncology Market
      Access and Pricing
      AstraZeneca
    • Thursday, October 20

      6:55am - 7:00am

      Opening Comments

      7:00am - 8:00am

      Near-Term Oncology Drug Trend and Pipeline Review

      Moderator:

      Cheryl Allen, RPh, BSPharm
      Chief Growth Officer
      PANTHERx Rare Pharmacy

      Faculty:

      Dipti Shah, PharmD
      Senior Clinical Program Manager, CVS Health
      Ela Lourido, MBA
      VP, Biopharma Services, Biologics by McKesson
      Joel Sandler, PhD
      Principal, BioConsilting
      Cancer Cell Therapy Lead, Lumanity
      8:00am - 8:45am

      Economic Trends and Forecast in Cancer Care

      Moderator:

      Barbara McAneny, MD
      Past President, American Medical Association
      Chair, National Cancer Care Alliance
      CEO, New Mexico Cancer Center

      Faculty:

      Murray Aitken, MBA
      Executive Director, IQVIA Institute for Human Data Science
      Bruce Pyenson, FSA, MAAA
      Principal & Consulting Advisory, Milliman
      8:00am - 8:45am

      Clinician Leadership in Transforming Cancer Care

      Moderator:

      David Johnson, MD, MPH
      Clinical Operating Partner, Rubicon Founders

      Faculty:

      Ed Licitra, MD, PhD
      Chairman & CEO
      Astera Health Partners/Astera Cancer Care
      Robin Clarke, MD, MS
      CEO & Co-Founder
      Ursa Health
      Matt Resnick, MD, MPH
      Chief Medical Officer
      Embold Health
      James Hamrick, MD, MPH
      VP, Clinical Oncology
      Flatiron Health
      Raghu Ram, MD
      Value-Based Care Optimization and
      Community Clinical Collaboration
      Roswell Cancer Center
      8:45am - 9:30am

      Bundled Payments in Cancer Care: Surgery and Beyond

      Moderator:

      Len Lichtenfeld, MD
      Chief Medical Officer, Jasper Health

      Faculty:

      Deirdre Saulet, PhD
      Market VP, Oncology, Carrum Health
      Elaine Duck, RN
      Manager, Value Based Strategies and Analytics
      Memorial Sloan Kettering
      Barry Russo
      CEO, Center for Cancer and
      Blood Disorders
      8:45am - 9:45am

      Gene Therapy Value-Based Purchasing and the Impact of Medicaid Best Price Changes

      Moderator:

      Kim Caldwell, RPh
      Principal, Texas Star Healthcare Consulting, LLC

      Faculty:

      Mark Trusheim, MS
      Strategic Director, MIT NEWDIGS
      Michael Ciarmetaro, MBA
      Principal, Avalere Health
      9:30am - 9:45am

      Integra Connect Results Report on OCM

      Faculty:

      Jeffrey Scott, MD
      President & Chief Medical Officer, Integra Connect
      9:45am - 10:45am

      Lessons Learned from OCM That Should Be Incorporated into EOM and Future Cancer Care Models

      Moderator:

      Michael Kolodziej, MD
      Senior Advisor, ADVI Health

      Faculty:

      Sibel Blau, MD
      President & CEO, Quality Cancer Care Alliance Network
      Medical Director, Northwest Medical Specialties
      Jeff Patton, MD
      CEO, OneOncology
      Executive Chairman of the Board
      Tennessee Oncology
      Matt Miller, MD, MBA
      Chief Operating Officer
      The Oncology Institute of Hope and Innovation
      Marcus Neubauer, MD
      Chief Medical Officer
      The US Oncology Network
      Jeffrey Scott, MD
      President & Chief Medical Officer
      Integra Connect
      10:45am - 11:30am

      Community Cancer Care and Its Future Path Ahead

      Moderator:

      Bo Gamble
      Director, Quality and Value
      Community Oncology Alliance

      Faculty:

      Jeff Patton, MD
      CEO, OneOncology
      Michael DeLeo, MD
      Chief Medical Officer, Foundation Medical Partners
      Southern New Hampshire Medical Center
      Barbara McAneny, MD
      Past President, American Medical Association
      Chair, National Cancer Care Alliance
      CEO, New Mexico Cancer Center
      Nathan Walcker, MBA
      CEO, Florida Cancer Specialists

      Selling the Cell – Cost-Benefit Considerations for Complex Therapeutics

      Moderator:

      Joel Sandler, PhD
      Principal, BioConsilting, Cancer Cell Therapy Lead, Lumanity

      Faculty:

      Lucas de Breed, MBA, PhD
      Founder
      August Care
      Jie Zhang, PhD
      VP, Head of Global Value and Access
      Cell & Gene, Novartis
      Phil Cyr
      Senior VP
      Precision Value & Health
      Devin Murray, MBA
      Chief Operating Officer
      Cellevolve

      Clinical Research Organizations of the Future

      Moderator:

      Maurie Markman, MD
      President, Medicine and Science
      Cancer Treatment Centers of America

      Faculty:

      Robert Jones
      Chief Financial Officer
      Lightship
      Howard Burris, MD
      President, Clinical Operations and
      Chief Medical Officer
      Sarah Cannon
      Terri Matson
      Executive Director, Clinical and
      Translational Research
      VCU Massey Cancer Center
      11:30am - 12:15pm

      Unified Leadership Efforts to Address and Shape the Future of Cancer Care

      Moderator:

      William McGivney, PhD
      Managing Principal, McGivney Global Advisors

      Faculty:

      Clifford Hudis, MD, FACP, FASCO
      CEO, American Society of Clinical Oncology
      Nicolas Ferreyros
      Managing Director, Community Oncology Alliance
      Christian Downs, MHA, JD
      Executive Director
      Association of Community Cancer Centers
      Crystal Denlinger, MD
      SVP & Chief Scientific Officer, NCCN
      William Wood, MD, MPH
      Senior Medical Advisor
      American Society of Hematology
      Research Collaborative
      12:30pm - 1:30pm

      Lunch Panel

      Moderator:

      Burt Zweigenhaft, PhD, DLitt
      Executive Director & Co-Founder, AVBCC

      Faculty:

      Larry Kudlow
      Host of "Kudlow" on Fox Business Network
      Former Director, National Economic Council
      1:30pm - 2:30pm

      Washington Legislation and Policy Impacts

      Moderator:

      John O'Brien, PharmD, MPH
      President & CEO, National Pharmaceutical Council

      Faculty:

      Anand Shah, MD, MPH
      Operating Advisor, Clayton Dubilier & Rice
      Former Deputy Commissioner for Medical and Scientific Affairs, FDA
      2:30pm - 3:15pm

      Supporting Patients: We Must Do Better

      Moderator:

      Elizabeth Franklin, PhD, MSW
      Head, US Public Affairs and Patient Advocacy, Sanofi

      Faculty:

      Erica Fischer-Cartlidge, DNP, CNS, AOCNS, EBP-C
      Chief Clinical Officer, ONS
      Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBSN
      Program Director, Academy of Oncology Nurse & Patient Navigators
      Alan Balch, PhD
      CEO, Patient Advocate Foundation
      Patricia Goldsmith
      CEO, CancerCare
      Tony Blau
      President & CEO, All4Cure

      Payers’ Initiatives: Future Impact on Cancer Care

      Moderator:

      Michael Kolodziej, MD
      Senior Advisor, ADVI Health

      Faculty:

      Mark Chassay, MD, MEd, MBA
      Chief Medical Officer
      Blue Cross Blue Shield of Texas
      Bryan Loy, MD
      Physician Lead
      Oncology Laboratory and
      Personalized Medicine
      Humana
      Lucy Ruwitch Langer, MS, MD
      National Medical Director
      Oncology and Genomics
      UnitedHealthcare
      Ross Hoffman, MD
      Chief Medical Officer, Centene
      3:15pm - 4:00pm

      What Is the Role of Centers of Excellence?

      Moderator:

      William McGivney, PhD
      Managing Principal, McGivney Global Advisors

      Faculty:

      Tim Kubal, MBA, MD
      Senior Medical Director
      Moffitt Cancer Center
      Howard Burris, MD
      President, Clinical Operations and Chief Medical Officer
      Sarah Cannon
      Christian Downs, JD
      Executive Director
      Association of Community Cancer Centers

      Employers

      Moderator:

      Art Taft, MBA, MEng
      Managing Director, Medworks Consulting, LLC

      Faculty:

      Lisa Comerose, RN
      VP, Clinical Operations
      MarshMcLennan Agency
      Peter Hayes
      President & CEO
      Healthcare Purchaser of Maine
      Chris Kim
      Director, Global Head of Employee
      Experience - Benefit -
      Wellness, KKR
      Monte Masten, MD
      Chief Medical Officer
      MarshMcLennan Agency
      Carole Mendoza
      VP, Benefits & Global
      Benefits Expert, Voya

      340B Program: Current State and Outcomes

      Moderator:

      Sherri Faber, RPh, MHA
      President & CEO, 340B Compliance Partners

      Faculty:

      Jeremy Docken
      Founder, Docken Advisory
      Visiting Fellow, Life Sciences
      Pioneer Institute
      Shannon Stephenson, CPA
      CEO, Cempa Community Care
      Ted Slafsky
      Publisher & CEO
      340B Report
      Aaron Vandervelde, MBA
      Managing Director
      Berkley Research Group

      Pharmaceutical Industry Role in Value-Based Agreements

      Moderator:

      William McGivney, PhD
      Managing Principal, McGivney Global Advisors

      Faculty:

      Ravinder Dhawan, PhD
      VP, and Head of Oncology, Center for Observational and
      Real-World Evidence, Merck
      Beth Hamilton, MBA
      VP, Global Oncology Market Access and Pricing
      AstraZeneca
      Brian Morrissey
      VP, Oncology National Customer Group, Pfizer
      John O'Brien, PharmD, MPH
      President & CEO, National Pharmaceutical Council
      Annette Powers, PharmD, MBA
      VP, Bristol Myers Squibb
      4:00pm - 4:45pm

      Precision Medicine’s Role and Impact on Value-Based Agreements

      Moderator:

      Deirdre Saulet, PhD
      Market VP, Oncology, Carrum Health

      Faculty:

      Ira Klein, MD, MBA, FACP
      VP, Medical Affairs & Payer Relations, Tempus
      Joe McKenna
      VP of Commercial Partnerships & Growth Strategy
      GRAIL
      John Fox, MD
      Senior Medical Director for the Americas, Illumina
      Mark Hiatt, MD, MBA, MS
      VP, Guardant Health

      340B Programs: A Look at Solutions

      Moderator:

      Mesfin Tegenu
      CEO, RxParadigm

      Faculty:

      Brian Clark
      CEO, Greater Philadelphia Health Action
      Eric Percher
      Senior Analyst
      Pharma Supply Chain & HCIT
      Nephron Research LLC
      Jackson Hammond
      Health Care Analyst
      The American Action Forum
      4:45pm - 5:30pm

      Future Models of Precision Medicine

      Moderator:

      Bruce Quinn, MD, PhD
      Principal, Bruce Quinn Associates LLC

      Faculty:

      Ira Klein, MD, MBA, FACP
      VP, Medical Affairs & Payer Relations, Tempus
      Mark Hiatt, MD, MBA, MS
      VP, Guardant Health
      Peter Bach, MD
      Chief Medical Officer, Delfi Diagnostics
      Stan Skrzypczak, MS, MBA
      Managing Partner, 5Prime Life Science Consulting, Inc.

      Disparities and the Impact on Cancer Care

      Moderator:

      Sybil Green, JD, RPh, MHA
      Diversity and Inclusion Officer
      American Society of Clinical Oncology

      Faculty:

      Edith Mitchell, MD, MACP, FCPP, FRCP
      Clinical Professor of Medicine and Medical Oncology
      Department of Medical Oncology
      Director, Center to Eliminate Cancer Disparities; Associate Director, Diversity Affairs
      Sidney Kimmel Cancer Center at Jefferson; Member, President's Cancer Panel
      116th President, National Medical Association
      Robert Winn, MD
      Director & Lipman Chair, Oncology
      VCU Massey Cancer Center
      Otis Brawley, MD
      Bloomberg Distinguished Professor
      Johns Hopkins University

      Addressing the Current PBM Models and Impact on Value-Based Care

      Moderator:

      Jayson Slotnik, JD, MPH
      Partner, Health Policy Strategies

      Faculty:

      Mesfin Tegenu
      CEO, RxParadigm
      Mike Ellis
      CEO, Maxor National Pharmacy Services
      Mostafa Kamal
      CEO, Magellan Rx
      5:30pm - 6:15pm

      Cancer Research and the Road Ahead

      Moderator:

      Rob Butcher
      President & CEO, Swim Across America

      Faculty:

      Nancy Daly, MS, MPH
      Chief Executive Officer
      Conquer Cancer
      The ASCO Foundation
      Jedd Wolchok, MD
      Meyer Director
      Sandra and Edward Meyer Cancer Center
      Weill Cornell Medicine
      Andrea Cercek, MD
      Section Head, Colorectal Cancer & Co-Director
      Center for Young Onset Colorectal and Gastrointestinal Cancers
      Memorial Sloan Kettering Cancer Center
      Lucio Gordan, MD
      Chief Medical Officer
      Therapeutics & Analytics; Past President
      Florida Cancer Specialists
      Steven Rosen, MD
      Provost and Chief Scientific Officer
      City of Hope
      Robyn Gartrell, MD
      Assistant Professor of Pediatrics
      CUMC
      Peter Yu, MD
      ASCO Young Investigator Recipient
      Varun Narendra, MD, PhD
      ASCO Young Investigator Recipient
      6:15pm - 9:00pm

      Swim Across America Reception

    • Friday, October 21

      7:00am - 8:00am

      Radiation Oncology: Under Clinical Pathways, Transparency, and with Risk Share

      Moderator:

      Jordan Johnson, MSHA, iMpaCT
      Chief Innovation Officer, Oncospark

      Faculty:

      Arpit Chhabra, MD
      Director, Education & Radiation Oncology
      New York Proton Center
      Join Luh, MD, FACP, FACR
      Radiation Oncologist, Providence Health
      St. Joseph's Hospital
      Al Lawson, PhD
      MilliSVP, Radiation Oncology Services
      Tennessee Oncologyman
      Sean McBride, MD, MPH
      Radiation Oncologist
      Memorial Sloan Kettering Cancer Center
      Vivek Kavadi, MD, FASTRO
      Chief Radiation Oncologist
      The US Oncology Network
      Jacob Philip, MBA
      Founder, MedLever

      Medication Access, Cost and Adherence – Root Cause of High Cost, Low Quality Health Outcomes

      Moderator:

      Lillie Shockney, RN, BS, MAS, HON-ONN-CG
      University Distinguished Service Professor of Breast Cancer
      Professor of Surgery, Johns Hopkins University School of Medicine
      Co-Founder, Academy of Oncology Nurse and Patient Navigators

      Faculty:

      Billie Lynn Allard, RN, MSN, FAAN
      Nursing Administrative Consultant
      Southwestern Vermont Health Care
      Jennifer Edwards, RN, BSN, OCN
      RN Associate Director
      Clinical Services - Department of RN Navigators
      Banner Health
      Michael Reff, RPh, MBA
      Founder & Executive Director, NCODA
      Christopher Marcum, PharmD
      VP Enterprise Pharmacy
      Cancer Treatment Centers of America Global, LLC.
      part of City of Hope

      The Business Path: From Innovation to Market Access

      Moderator:

      William McGivney, PhD
      Managing Partner, McGivney Global Advisors

      Faculty:

      John Fox, MD
      Senior Medical Director for the Americas
      Illumina
      Howard Burris, MD
      President, Clinical Operations and Chief Medical Officer
      Sarah Cannon
      Robert Geller, MD
      Chief Medical Officer
      Ararive, Inc.
      Ross Hoffman, MD
      Chief Medical Officer
      Centene
      Stan Skrzypczak, MS, MBA
      Managing Partner
      5Prime Life Science Consulting, Inc.

      FTC Launces Investigation into PBMs

      Moderator:

      Jayson Slotnik, JD, MPH
      Partner, Health Policy Strategies

      Faculty:

      Brad Wasser, JD
      Associate, Duane Morris
      Jonathan Levitt, Esq.
      Founding Partner, Frier Levitt
      8:00am - 9:00am

      Utilization of Pathways in Precision Medicine to Impact Patient Care

      Moderator:

      Kjel Johnson, PharmD
      VP, CVS Health

      Faculty:

      Dennis Flannelly, MBA
      Head of Precision Medicine
      Merck
      James Hamrick, MD, MPH
      VP, Clinical Oncology, Flatiron Health
      Ray Page, DO, PhD, FACOI, FASCO
      President & Director of Research
      The Center for Cancer and Blood Disorders
      Lyn Fitzgerald
      VP, Oncology Sales, Ontanda

      Drug Pricing and Transformation Realities and Implications on the Road Ahead

      Moderator:

      William McGivney, PhD
      Managing Partner, McGivney Global Advisors

      Faculty:

      Kent Rogers, MBA
      Chief Customer Officer
      EQRx
      Bhavesh Ashar
      Chief Commercial Officer
      SpringWorks
      Tesh Khullar
      CEO & Co-Founder
      House Rx

      Leadership for Navigation: How Leadership Promotes Values of Navigation for Sustainability

      Moderator:

      Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN
      Program Director, Academy of Oncology Nurse & Patient Navigators

      Faculty:

      Andrea Dwyer
      Program Director
      Colorado Cancer Screening Program
      Emily Gentry, RN, BSN, OCN, HON-ONN-CG
      Senior Director, Education & Program Development, AONN+
      Jeanne Silver, MSN, RN-BC, CMSRN, CN-BN
      Assistant VP, Navigation and Oncology Access
      RWJ Barnabas Health System
      New Jersey Oncology Services

      New Site of Cancer Care Models

      Moderator:

      Connie Sullivan, BSPharm
      President & CEO, National Home Infusion Association

      Faculty:

      Nathan Handley, MD, MBA
      Assistant Professor, Medical Oncology
      Sidney Kimmel Cancer Center
      Jefferson Health
      John Hennessy, MBA, CMPE
      SVP, Strategist
      Valuate Health Consultancy
      Roger Brito, DO
      Divisional Head
      Enterprise Oncology
      CVS Health
      David Wierz
      Principal, Exponent
      8:45am - 9:30am

      Out of Pocket Out of Time: Evolving to Address Financial Toxicity and Designing for the Future

      Moderator:

      Marianne Gandee
      Senior Director, Team Lead, Advocacy and Professional Relations
      Pfizer Oncology

      Faculty:

      Sumner Madden
      Executive Director
      Access Services and Reimbursement
      AstraZeneca
      Alex Tabarrok, PhD
      Bartley J. Madden Chair in Economics
      Mercatus Center at George Mason University
      Pam Traxel
      Senior VP, ACS CAN
      9:00am - 10:00am

      Biosimilars

      Faculty:

      Neal Lambert
      Senior Director & Team Lead Pricing
      Strategy US Biosimilar, Pfizer
      Sonia Oskouei, PharmD
      VP, Biosimilars
      Cardinal Health
      Harsher Singh, MBA
      SVP, Amneal Pharmaceuticals
      Ross Hoffman, MD
      Chief Medical Officer
      Centene

      Oncology Drug Benefit Designs and Pricing Realities Now and Tomorrow

      Moderator:

      Michael Kolodziej, MD
      Senior Advisor, ADVI Health

      Faculty:

      Deborah Kamin, RN, PhD
      VP, Policy & Advocacy
      American Society of Clinical Oncology
      Andrew Cournoyer
      Senior VP, Director, Access Experience Team
      PRECISIONvalue
      Bryan Loy, MD
      Physician Lead
      Oncology Laboratory and
      Personalized Medicine
      Humana
      10:00am - 11:00am

      New Patient-Centric Cancer Care Models

      Moderator:

      Len Lichtenfeld, MD
      Former Chief Medical Officer
      American Cancer Society

      Faculty:

      Greg Orr
      Chief Commercial Officer
      Jasper Health
      Andrew Norden, MD, MPH, MBA
      Chief Medical Officer
      OncoHealth
      Bobby Green, MD
      Co-Founder, President &
      Chief Medical Officer, Thyme
      Lavi Kwiatkowsky
      CEO & Founder, Canopy

      The Impact Pathways Have on Outcomes and Value

      Moderator:

      Lalan Wilfong, MD
      VP, Payer Relations and Practice Transformations
      McKesson

      Faculty:

      Roger Brito, DO
      Divisional Head, Enterprise Oncology
      CVS Health
      Andrew Hertler, MD, FACP
      Chief Medical Officer
      New Century Health
      Marcus Neubauer, MD
      Chief Medical Officer
      The US Oncology Network
      Yale Podnos, MD, MPH, FACS
      Chief medical Officer
      President of Practice
      The Oncology Institute for Hope and Innovation
      Jeffrey Scott, MD
      President & Chief Medical Officer
      Integra Connect

      Oncology Drug Supply Channels and the Move to Smart Networks and Supporting Value-Based Agreements

      Moderator:

      Michael Agostino, RPh
      Former President, NASP

      Faculty:

      Heather Morel, PhD
      SVP & President, Provider Solutions, McKesson
      Jennifer Sherak
      SVP & President, Specialty Physician Services
      AmerisourceBergen
      Dan Duran
      SVP & GM
      Provider Solutions
      Cardinal Health Specialty Solutions

      Revenue Cycle Management System and Ability to Manage Value-Based Agreements

      Moderator:

      Sheila Sferrella, MAS
      Executive VP, Regents Health Resources, LLC

      Faculty:

      Parag Shah
      President, Practice Solutions
      Integra Connect
      Ron DiGiaimo, MBA, FACHE
      Chairman of the Board
      Revenue Cycle Coding Strategies
      Sarah Cevallos
      VP, Practice Financial Health
      Flatiron Health
      Brian Gockerman
      CEO, Unlimited Systems
      11:00am - 12:00pm

      Telehealth/Digital Health and Integration into Care Management

      Moderator:

      Ann Mond Johnson
      CEO, ATA

      Faculty:

      Vidya Raman-Tangella, MHA, MD
      Chief Medical Officer, Teladoc Health, Inc
      Bob Gold
      Chief Behavioral Technologist & CEO
      GoMo Health
      David Wierz
      Principal, Exponent
      Lavi Kwiatkowsky
      CEO & Founder, Canopy

      Practice Transformation Through Value-Based Analytics

      Moderator:

      Nina Chavez, MBA, FACHE
      Senior Advisor, Flatiron Health

      Faculty:

      Sibel Blau, MD
      President & CEO, Quality Cancer Care Alliance Network
      Medical Director, Northwest Medical Specialties
      Basit Chaudhry, MD, PhD
      Founder, Tuple Health
      Susan Hoang, PharmD
      VP, Oncology Analytics, McKesson
      Aaron Lyss
      Senior Director, Strategic Payer Relations
      OneOncology,
      Matt Miller, MD, MBA
      Chief Operating Officer
      The Oncology Institute of Hope and Innovation
      Jeffrey Scott, MD
      President & Chief Medical Officer, Integra Connect

      Medically Integrated Pharmacy and Future Models of Integration

      Moderator:

      Michael Reff, RPh, MBA
      Founder & Executive Director, NCODA

      Faculty:

      Ray Bailey, RPh
      Pharmacy Director
      Florida Cancer Specialists
      Marci Conlin
      VP, Pharmacy Network Management
      Prime Therapeutics
      Scott Freeswick, MS PharmD
      VP & Chief Pharmacy Officer
      Memorial Sloan Kettering Cancer Center
      Brian Morrissey
      VP, Oncology National Customer Group, Pfizer

      Technology Transfer for Cell Therapy and Gene Therapy: Will These Advances Be Provided by Community Hospital Cancer Programs?

      Moderator:

      William McGivney, PhD
      Managing Principal, McGivney Global Advisors

      Faculty:

      Bradley Monk, MD, FACS, FACOG
      Professor, Obstetrics & Gynecology
      University of Arizona College of Medicine
      Bryan Loy, MD
      Physician Lead
      Oncology Laboratory and
      Personalized Medicine
      Humana
      Michael Wong, MD, PhD, FRCPC
      Professor, Department of Melanoma
      Medical Oncology
      MD Anderson
      12:00pm - 12:30pm

      Lunch

      12:30pm - 1:15pm

      Keynote with Scott Gottlieb

      Moderator:

      Burt Zweigenhaft, PhD, DLitt
      Executive Director & Co-Founder

      Faculty:

      Scott Gottlieb, MD
      Former Commissioner, FDA
      1:15pm - 2:00pm

      Industry Perspectives on Cancer Care

      Moderator:

      John O'Brien, PharmD, MPH
      President & CEO, National Pharmaceutical Council

      Faculty:

      John Murphy, III
      Chief Policy Officer Deputy Counsel
      Healthcare, BIO
      Randy Burkholder
      VP, Policy and Research
      PhRMA

      The Evolving Role of Social Determinants of Health in Value-Based Care Goals

      Moderator:

      Kathy Oubre, MS
      CEO, Pontchartrain Cancer Center

      Faculty:

      Karen Winkfield, MD, PhD
      Executive Director, Meharry-Vanderbilt Alliance
      2:00pm - 3:00pm

      Advocacy and Emerging Roles in Cancer Care

      Moderator:

      Rose Gerber
      Director of Patient Advocacy & Education
      Patient Advocacy Network
      Community Oncology Alliance

      Faculty:

      Patricia Goldsmith
      CEO, CancerCare
      Elizabeth Franklin, PhD, MSW
      Head, Us Public Affairs and Patient Advocacy
      Oncology, Sanofi
      Theresa West
      Chief Commercial Officer
      Patient Discover

      Payer and Provider Innovative Value-Based Agreement

      Moderator:

      Steven Peskin, MD, MBA, MACP
      Executive Medical Director
      Population Health and Transformation
      Horizon BCBS

      Faculty:

      Jay Scott
      Director
      Managed Care
      Minnesota Oncology
      Rhonda Henschel, MBA
      Senior Director
      Payer Solutions
      The US Oncology Network
      Jackie Popehn
      Director of Care Reinvention
      Blue Cross Blue Shield Minnesota
      Stacie Mason
      Provider Partner Principal
      Provider Relations
      Blue Cross Blue Shield Minnesota

      AI and ML Decision Support Models

      Moderator:

      Zahra Eftekhari, MS
      Executive Director
      Applied AI and Data Science
      City of Hope

      Faculty:

      Lyn Fitzgerald
      VP, Oncology Sales
      Ontada
      Lily Peng, MD, PhD
      Product Management
      Google
      Susan Weidner
      SVP, IntrinsiQ Specialty Solutions
      Bruce Edelen
      Senior VP
      PRECISIONxtract
      Amy Valley, PharmD
      VP, Clinical Strategy and Technology Solutions
      Cardinal Health

      Drug/Biologic Development: To Market; To Out-License; To Be Acquired

      Moderator:

      William McGivney, PhD
      Managing Partner, McGivney Global Advisors

      Faculty:

      Alex Santini
      Senior Manager, Upstream Partners
      Deniz Razon, MBA
      Head, Commercial, Servier
      Vicki Vakiener
      Board of Director Member
      Arrowhead Pharmaceuticals
      3:00pm - 3:45pm

      Disruption or Progress? The 5 Top Things We Must Address to Improve the Future of Cancer Care

      Faculty:

      Michael Kolodziej, MD
      Senior Advisor, ADVI Health
      William McGivney, PhD
      Managing Partner, McGivney Global Advisors
      John O'Brien, PharmD, MPH
      President & CEO
      National Pharmaceutical Council
      Burt Zweigenhaft, PhD, DLitt
      Executive Director & Co-Founder, AVBCC

    *Agenda subject to change.

  • 2022 AVBCC Summit - Speaker Affiliations
  • Location

    New York Athletic Club
    180 Central Park South, New York, NY 10019

    Hotels

    Please Note: There are no lodging accommodations at the New York Athletic Club. AVBCC does not have group rates at the hotels listed above. Rates are subject to change on a daily basis.

    Transit Information

    SUBWAY LINES

    • W – N – Q – W
    • A, C, or 1 train to 59th Street – Columbus Circle

    NEAREST SUBWAY STATION

    • 57 Street Subway Station (7th Avenue & 57th Street)

    PARKING

    • GMC: 200 Central Park South (59th Street & 7th Avenue)
    • Icon Parking System: 125 West 58th Street (58th Street & 7th Avenue)
    • Icon Parking System: 157 West 57th Street (57th Street & 7th Avenue)

    Dress Code

    MEN

    • Business attire; jackets and ties are not required in most areas.
    • Slacks or khakis are permitted with collared dress shirts, which must be tucked in at all times.
    • Jackets and ties are required in the Main Dining Room and Cocktail Lounge.

    WOMEN

    • Suits, dresses, sweaters, blouses, skirts, and tailored pants are permitted.
    • Halter tops, leggings, and clothing that reveals midriffs remain prohibited.

    NOT PERMITTED (Men & Women)

    • Sneakers, athletic shoes, flip-flops, clogs, and canvas boating shoes.
    • Jeans and other denim wear, shorts, T-shirts, and athletic wear.

    Mobile Voice and Data Policy

    Mobile phones and devices are prohibited in all facilities of the Club except guest rooms, enclosed phone booths, and the Lobby Communication Center. This includes speaking on a cell phone, e-mailing, texting, games, reading, and Internet browsing on a mobile device. Conference attendees may use their device in the conference meeting space.

  • How to Sponsor the 2022 AVBCC Summit

    Sponsoring the AVBCC annual summit will provide you with the opportunity to identify qualified leads on the spot, build and develop business relationships, and have unprecedented networking opportunities.

    If you are interested in sponsoring the 2022 AVBCC Summit, please click the button below and submit an application by completing the form. Thank you.

    AVBCC Summit Sponsorship Application

    Who Should Sponsor?

    All Stakeholders in the Cancer Care Ecosystem

    • Oncologists and Hematologists
    • Nurses
    • Oncology Nurse Navigators
    • Pathologists and Geneticists
    • Pharmacists, Practice Administrators
    • Practice Managers
    • Patient Advocacy Organizations
    • Managed Care Organizations
    • Insurance Companies
    • Third-Party Payers
    • Integrated Health Delivery Systems
    • Cancer Centers of Excellence
    • Medical Directors, Pharmacy Directors
    • Investors, Pharmaceutical and Biotech

    Reasons Your Company Should Sponsor

    • Meet with decision makers from leading oncology institutions and payer organizations
    • Demonstrate innovative products and services
    • Position your company as an industry leader
    • Gain exposure to strategic decision makers
    • Expand business opportunities with existing customers
    • Establish strategic partnerships
  • 2022 AVBCC Summit FAQs

    When and where will the 2022 AVBCC Summit take place?

    The 2022 AVBCC Summit will take place on October 19-21, 2022 in person at the New York Athletic Club (NYAC) in New York, NY, with a virtual simulcast.

    Are health and safety practices in place at the venue?

    In keeping with the New York State guidelines, NYAC and the Summit organizers will be limiting the capacity of in-person attendance. Attendees will be asked to wear masks in public spaces and observe social distancing.

    Where can I find the schedule of events?

    Please see the Full Agenda, located here.

    Note the agenda is subject to change, please check back for updates.

    How much does it cost to attend the Summit?

    The price for the Summit is $699 for the in-person event and $399 for the virtual pass.

    How can I register for the Summit?

    The in-person event in NYAC is on a first come, first served basis due to limited capacity per state guidelines. To register for the Summit, please visit the Overview tab to request your invite.

    When will I receive my Summit invite?

    The Summit organizers will begin responding to invite requests on Friday, July 29, 2022.

    How can I sponsor the Summit?

    If you are interested in sponsoring the event, please complete the sponsor information form on the Sponsors tab.

    How can I receive Summit updates?

    AVBCC will send e-mails periodically to update you on the agenda, event happenings, logistics and newsletters. Please make sure that the e-mail address, This email address is being protected from spambots. You need JavaScript enabled to view it., is in your safe senders list to ensure you are receiving all important information.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: